Dapagliflozin 10 mg/Pioglitazone 30 mg/Metformin HCl 1000 mg Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
Diabete Mellitus
Boryung Pharmaceutical Co., Ltd40 enrolled1 locationNCT07083401
Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)
Diabetes Mellitus
Boryung Pharmaceutical Co., Ltd52 enrolled1 locationNCT07083388